Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 115

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition

Dashtbani-Roozbehani, Abolfazl, Brown, Melissa H. · 2021 · Antibiotics

Abstract

The increasing emergence of antimicrobial resistance in staphylococcal bacteria is a major health threat worldwide due to significant morbidity and mortality resulting from their associated hospital- or community-acquired infections. Dramatic decrease in the discovery of new antibiotics from the pharmaceutical industry coupled with increased use of sanitisers and disinfectants due to the ongoing COVID-19 pandemic can further aggravate the problem of antimicrobial resistance. Staphylococci utilise multiple mechanisms to circumvent the effects of antimicrobials. One of these resistance mechanisms is the export of antimicrobial agents through the activity of membrane-embedded multidrug efflux pump proteins. The use of efflux pump inhibitors in combination with currently approved antimicrobials is a promising strategy to potentiate their clinical efficacy against resistant strains of staphylococci, and simultaneously reduce the selection of resistant mutants. This review presents an overview of the current knowledge of staphylococcal efflux pumps, discusses their clinical impact, and summarises compounds found in the last decade from plant and synthetic origin that have the potential to be used as adjuvants to antibiotic therapy against multidrug resistant staphylococci. Critically, future high-resolution structures of staphylococcal efflux pumps could aid in design and development of safer, more target-specific and highly potent efflux pump inhibitors to progress into clinical use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antibiotics10121502

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 296

  1. Reinl, 2016, UN declaration on antimicrobial resistance lacks targets, Lancet, 388, 1365, 10.1016/S0140-6736(16)31769-X · doi:10.1016/s0140-6736(16)31769-x
  2. Aslam, 2018, Antibiotic resistance: A rundown of a global crisis, Infect. Drug Resist., 11, 1645, 10.2147/IDR.S173867 · DOI · Paper page
  3. Coque, 2019, Defining and combating antibiotic resistance from One Health and Global Health perspectives, Nat. Microbiol., 4, 1432, 10.1038/s41564-019-0503-9 · DOI · Paper page
  4. Guo, 2020, Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus, Front. Cell. Infect. Microbiol., 10, 107, 10.3389/fcimb.2020.00107 · DOI · Paper page
  5. Loss, 2019, Staphylococcus aureus small colony variants (SCVs): News from a chronic prosthetic joint infection, Front. Cell. Infect. Microbiol., 9, 363, 10.3389/fcimb.2019.00363 · DOI
  6. Yan, 2019, Surviving as a community: Antibiotic tolerance and persistence in bacterial biofilms, Cell Host Microbe, 26, 15, 10.1016/j.chom.2019.06.002 · DOI · Paper page
  7. Skandalis, N., Maeusli, M., Papafotis, D., Miller, S., Lee, B., Theologidis, I., and Luna, B. (2021). Environmental Spread of Antibiotic Resistance. Antibiotics, 10. · DOI
  8. Trinh, 2018, One health relationships between human, animal, and environmental microbiomes: A mini-review, Front. Public Health, 6, 235, 10.3389/fpubh.2018.00235 · DOI · Paper page
  9. Collignon, P.J., and McEwen, S.A. (2019). One health—Its importance in helping to better control antimicrobial resistance. Trop. Med. Infect. Dis., 4. · DOI · Paper page
  10. Cay, 2014, Molecular diagnosis contributing for multi-drug resistant infection control, Curr. Treat. Options Infect. Dis., 6, 17, 10.1007/s40506-013-0006-9 · DOI
  11. 2017, Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms, Clin. Infect. Dis., 65, 644, 10.1093/cid/cix411 · DOI · Paper page
  12. Knight, 2021, Antimicrobial resistance and COVID-19: Intersections and implications, eLife, 10, e64139, 10.7554/eLife.64139 · DOI · Paper page
  13. Kampf, 2018, Challenging biocide tolerance with antiseptic stewardship, J. Hosp. Infect., 100, e37, 10.1016/j.jhin.2018.07.014 · doi:10.1016/j.jhin.2018.07.014
  14. Paul, 2019, Biocides and health-care agents are more than just antibiotics: Inducing cross to co-resistance in microbes, Ecotoxicol. Environ. Saf., 174, 601, 10.1016/j.ecoenv.2019.02.083 · DOI
  15. Blanco, P., Hernando-Amado, S., Reales-Calderon, J.A., Corona, F., Lira, F., Alcalde-Rico, M., Bernardini, A., Sanchez, M.B., and Martinez, J.L. (2016). Bacterial multidrug efflux pumps: Much more than antibiotic resistance determinants. Microorganisms, 4. · DOI · Paper page
  16. Hoffman, P.S. (2020). Antibacterial discovery: 21st century challenges. Antibiotics, 9. · DOI
  17. Venter, 2019, Reversing resistance to counter antimicrobial resistance in the World Health Organisation’s critical priority of most dangerous pathogens, Biosci. Rep., 39, BSR20180474, 10.1042/BSR20180474 · DOI
  18. Leitão, J.H. (2020). New insights into antibacterial compounds: From synthesis and discovery to molecular mechanisms of action. Antibiotics, 9. · doi:10.3390/antibiotics9080471
  19. Yu, 2020, Circumventing antimicrobial-resistance and preventing its development in novel, bacterial infection-control strategies, Expert Opin. Drug Deliv., 17, 1151, 10.1080/17425247.2020.1779697 · DOI
  20. Tyers, 2019, Drug combinations: A strategy to extend the life of antibiotics in the 21st century, Nat. Rev. Microbiol., 17, 141, 10.1038/s41579-018-0141-x · DOI · Paper page
  21. Wright, 2016, Antibiotic adjuvants: Rescuing antibiotics from resistance, Trends Microbiol., 24, 862, 10.1016/j.tim.2016.06.009 · DOI · Paper page
  22. Hancock, 2012, Adaptive and mutational resistance: Role of porins and efflux pumps in drug resistance, Clin. Microbiol. Rev., 25, 661, 10.1128/CMR.00043-12 · DOI · Paper page
  23. Costa, 2013, Multidrug efflux pumps in Staphylococcus aureus: An update, Open Microbiol. J., 7, 59, 10.2174/1874285801307010059 · DOI · Paper page
  24. 2016, Synergism between antibiotics and plant extracts or essential oils with efflux pump inhibitory activity in coping with multidrug-resistant staphylococci, Phytochem. Rev., 15, 651, 10.1007/s11101-016-9458-0 · DOI
  25. Otto, 2009, Staphylococcus epidermidis—The ‘accidental’ pathogen, Nat. Rev. Microbiol., 7, 555, 10.1038/nrmicro2182 · DOI · Paper page
  26. França, A., Gaio, V., Lopes, N., and Melo, L.D. (2021). Virulence factors in coagulase-negative Staphylococci. Pathogens, 10. · DOI
  27. Le, 2015, Quorum-sensing regulation in staphylococci—An overview, Front. Microbiol., 6, 1174, 10.3389/fmicb.2015.01174 · DOI · Paper page
  28. Heilmann, 2019, Are coagulase-negative staphylococci virulent?, Clin. Microbiol. Infect., 25, 1071, 10.1016/j.cmi.2018.11.012 · DOI · Paper page
  29. Monsen, 2012, Coagulase-negative staphylococci: Update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus, Eur. J. Clin. Microbiol. Infect. Dis., 31, 7, 10.1007/s10096-011-1270-6 · DOI · Paper page
  30. Yong, 2019, Biofilm formation by staphylococci in health-related environments and recent reports on their control using natural compounds, Crit. Rev. Microbiol., 45, 201, 10.1080/1040841X.2019.1573802 · DOI
  31. Le, 2017, Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period, Epidemiol. Infect., 145, 2631, 10.1017/S0950268817001571 · DOI
  32. Banerjee, 2021, Anandamide alters the membrane properties, halts the cell division and prevents drug efflux in multidrug resistant Staphylococcus aureus, Sci. Rep., 11, 1, 10.1038/s41598-021-88099-6 · DOI
  33. Jiang, 2019, Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation, Proc. Natl. Acad. Sci. USA, 116, 3722, 10.1073/pnas.1812066116 · DOI
  34. MacIntyre, 2017, Pandemics, public health emergencies and antimicrobial resistance-putting the threat in an epidemiologic and risk analysis context, Arch. Public Health, 75, 1, 10.1186/s13690-017-0223-7 · DOI
  35. Miragaia, 2018, Factors contributing to the evolution of mecA-mediated beta-lactam resistance in Staphylococci: Update and new insights from whole genome sequencing (WGS), Front. Microbiol., 9, 2723, 10.3389/fmicb.2018.02723 · DOI · Paper page
  36. Fishovitz, 2014, Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus, IUBMB Life, 66, 572, 10.1002/iub.1289 · DOI · Paper page
  37. Venter, 2017, Antimicrobial resistance in healthcare, agriculture and the environment: The biochemistry behind the headlines, Essays Biochem., 61, 1, 10.1042/EBC20160053 · DOI
  38. Wernli, 2017, Mapping global policy discourse on antimicrobial resistance, BMJ Glob. Health, 2, e000378, 10.1136/bmjgh-2017-000378 · DOI
  39. Sirijatuphat, R., Sripanidkulchai, K., Boonyasiri, A., Rattanaumpawan, P., Supapueng, O., Kiratisin, P., and Thamlikitkul, V. (2018). Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteremia. PLoS ONE, 13. · DOI
  40. Li, 2018, Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections, J. Orthop. Res., 36, 22, 10.1002/jor.23656 · DOI · Paper page
  41. Senn, 2016, The stealthy superbug: The role of asymptomatic enteric carriage in maintaining a long-term hospital outbreak of ST228 methicillin-resistant Staphylococcus aureus, MBio, 7, e02039-15, 10.1128/mBio.02039-15 · DOI
  42. Lee, 2017, Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization, J. Antimicrob. Chemother., 72, 2461, 10.1093/jac/dkx200 · DOI
  43. Hassoun, 2017, Incidence, prevalence, and management of MRSA bacteremia across patient populations—A review of recent developments in MRSA management and treatment, Crit. Care, 21, 211, 10.1186/s13054-017-1801-3 · DOI · Paper page
  44. Agostino, 2017, The increasing importance of community-acquired methicillin-resistant Staphylococcus aureus infections, Med. J. Aust., 207, 388, 10.5694/mja17.00089 · DOI
  45. Choo, 2017, Community-associated methicillin-resistant Staphylococcus aureus in nosocomial infections, Infect. Chemother., 49, 158, 10.3947/ic.2017.49.2.158 · DOI
  46. Kong, E.F., Johnson, J.K., and Jabra-Rizk, M.A. (2016). Community-associated methicillin-resistant Staphylococcus aureus: An enemy amidst us. PLoS Pathog., 12. · DOI
  47. Uehara, Y., Sasaki, T., Baba, T., Lu, Y., Imajo, E., Sato, Y., Tanno, S., Furuichi, M., Kawada, M., and Hiramatsu, K. (2019). Regional outbreak of community-associated methicillin-resistant Staphylococcus aureus ST834 in Japanese children. BMC Infect. Dis., 19. · DOI
  48. McDougal, 2010, Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States, Antimicrob. Agents Chemother., 54, 3804, 10.1128/AAC.00351-10 · DOI · Paper page
  49. Garoy, 2019, Methicillin-resistant Staphylococcus aureus (MRSA): Prevalence and antimicrobial sensitivity pattern among patients—A multicenter study in Asmara, Eritrea, Can. J. Infect. Dis. Med. Microbiol., 2019, 8321834, 10.1155/2019/8321834 · DOI · Paper page
  50. Choo, 2016, Treatment of methicillin-resistant Staphylococcus aureus bacteremia, Infect. Chemother., 48, 267, 10.3947/ic.2016.48.4.267 · DOI · Paper page
  51. Sarkar, 2017, A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics, MedChemComm, 8, 516, 10.1039/C6MD00585C · DOI · Paper page
  52. McGuinness, 2017, Vancomycin resistance in Staphylococcus aureus, Yale J. Biol. Med., 90, 269
  53. Wang, 2018, Insights into key interactions between vancomycin and bacterial cell wall structures, ACS Omega, 3, 37, 10.1021/acsomega.7b01483 · DOI
  54. Pantosti, 2007, Mechanisms of antibiotic resistance in Staphylococcus aureus, Future Microbiol., 2, 323, 10.2217/17460913.2.3.323 · DOI · Paper page
  55. Touati, 2021, Fitness cost of antibiotic resistance in Staphylococcus aureus: A systematic review, Microb. Drug Resist., 9, 1218, 10.1089/mdr.2020.0426 · DOI
  56. Malachowa, 2010, Mobile genetic elements of Staphylococcus aureus, Cell. Mol. Life Sci., 67, 3057, 10.1007/s00018-010-0389-4 · DOI · Paper page
  57. Haaber, 2017, Transfer of antibiotic resistance in Staphylococcus aureus, Trends Microbiol., 25, 893, 10.1016/j.tim.2017.05.011 · DOI · Paper page
  58. Bukowski, 2019, Prevalence of antibiotic and heavy metal resistance determinants and virulence-related genetic elements in plasmids of Staphylococcus aureus, Front. Microbiol., 10, 805, 10.3389/fmicb.2019.00805 · DOI
  59. Sargison, 2020, Advances in transposon mutagenesis of Staphylococcus aureus: Insights into pathogenesis and antimicrobial resistance, Trends Microbiol., 29, 282, 10.1016/j.tim.2020.11.003 · doi:10.1016/j.tim.2020.11.003
  60. Jamrozy, D., Coll, F., Mather, A.E., Harris, S.R., Harrison, E.M., MacGowan, A., Karas, A., Elston, T., Estee Torok, M., and Parkhill, J. (2017). Evolution of mobile genetic element composition in an epidemic methicillin-resistant Staphylococcus aureus: Temporal changes correlated with frequent loss and gain events. BMC Genomics, 18. · DOI
  61. Lewis, 2020, The science of antibiotic discovery, Cell, 181, 29, 10.1016/j.cell.2020.02.056 · DOI · Paper page
  62. Earls, M.R., Kinnevey, P.M., Brennan, G.I., Lazaris, A., Skally, M., O’Connell, B., Humphreys, H., Shore, A.C., and Coleman, D.C. (2017). The recent emergence in hospitals of multidrug-resistant community-associated sequence type 1 and spa type t127 methicillin-resistant Staphylococcus aureus investigated by whole-genome sequencing: Implications for screening. PLoS ONE, 12. · DOI
  63. Weigel, 2003, Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus, Science, 302, 1569, 10.1126/science.1090956 · DOI · Paper page
  64. Qureshi, N.K., Yin, S., and Boyle-Vavra, S. (2014). The role of the Staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus. PLoS ONE, 9. · DOI
  65. Xia, 2016, Nosocomial infection and its molecular mechanisms of antibiotic resistance, Biosci. Trends, 10, 14, 10.5582/bst.2016.01020 · DOI
  66. Nawrocki, 2014, Antimicrobial peptide resistance mechanisms of Gram-positive bacteria, Antibiotics, 3, 461, 10.3390/antibiotics3040461 · DOI
  67. Peacock, 2015, Mechanisms of methicillin resistance in Staphylococcus aureus, Annu. Rev. Biochem., 84, 577, 10.1146/annurev-biochem-060614-034516 · DOI · Paper page
  68. Tanaka, 2013, Structural basis for the drug extrusion mechanism by a MATE multidrug transporter, Nature, 496, 247, 10.1038/nature12014 · DOI · Paper page
  69. Hughes, 2015, Evolutionary consequences of drug resistance: Shared principles across diverse targets and organisms, Nat. Rev. Genet., 16, 459, 10.1038/nrg3922 · DOI · Paper page
  70. Melander, 2017, The challenge of overcoming antibiotic resistance: An adjuvant approach?, ACS Infect. Dis., 3, 559, 10.1021/acsinfecdis.7b00071 · DOI · Paper page
  71. Lamut, 2019, Efflux pump inhibitors of clinically relevant multidrug resistant bacteria, Med. Res. Rev., 39, 2460, 10.1002/med.21591 · DOI · Paper page
  72. Pu, 2016, Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells, Mol. Cell, 62, 284, 10.1016/j.molcel.2016.03.035 · DOI · Paper page
  73. Pu, 2017, Active efflux in dormant bacterial cells—New insights into antibiotic persistence, Drug Resist. Updates, 30, 7, 10.1016/j.drup.2016.11.002 · DOI
  74. Ebbensgaard, A.E., Løbner-Olesen, A., and Frimodt-Møller, J. (2020). The role of efflux pumps in the transition from low-level to clinical sntibiotic resistance. Antibiotics, 9. · DOI
  75. Henderson, 2021, Physiological Functions of Bacterial “Multidrug” Efflux Pumps, Chem. Rev., 121, 5417, 10.1021/acs.chemrev.0c01226 · DOI · Paper page
  76. Poole, 2002, Mechanisms of bacterial biocide and antibiotic resistance, J. Appl. Microbiol., 92, 55s, 10.1046/j.1365-2672.92.5s1.8.x · DOI · Paper page
  77. Ramaswamy, 2017, Molecular rationale behind the differential substrate specificity of bacterial RND multi-drug transporters, Sci. Rep., 7, 8075, 10.1038/s41598-017-08747-8 · DOI
  78. Piddock, 2006, Multidrug-resistance efflux pumps—Not just for resistance, Nat. Rev. Microbiol., 4, 629, 10.1038/nrmicro1464 · DOI · Paper page
  79. Hassan, 2019, Short-chain diamines are the physiological substrates of PACE family efflux pumps, Proc. Natl. Acad. Sci. USA, 116, 18015, 10.1073/pnas.1901591116 · doi:10.1073/pnas.1901591116
  80. Short, 2021, Spermidine and spermine are the natural substrates of the Acinetobacter baumannii AmvA multidrug efflux pump, Commun. Biol., 4, 1114, 10.1038/s42003-021-02629-6 · DOI
  81. Du, 2018, Multidrug efflux pumps: Structure, function and regulation, Nat. Rev. Microbiol., 16, 523, 10.1038/s41579-018-0048-6 · DOI · Paper page
  82. Alav, 2018, Role of bacterial efflux pumps in biofilm formation, J. Antimicrob. Chemother., 73, 2003, 10.1093/jac/dky042 · DOI · Paper page
  83. Schilcher, 2020, Staphylococcal biofilm development: Structure, regulation, and treatment strategies, Microbiol. Mol. Biol. Rev., 84, e00026-19, 10.1128/MMBR.00026-19 · DOI · Paper page
  84. Grkovic, 2002, Regulation of bacterial drug export systems, Microbiol. Mol. Biol. Rev., 66, 671, 10.1128/MMBR.66.4.671-701.2002 · DOI · Paper page
  85. Paulsen, 1996, Proton-dependent multidrug efflux systems, Microbiol. Rev., 60, 575, 10.1128/mr.60.4.575-608.1996 · doi:10.1128/mr.60.4.575-608.1996 · Paper page
  86. Sun, 2014, Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations, Biochem. Biophys. Res. Commun., 453, 254, 10.1016/j.bbrc.2014.05.090 · DOI · Paper page
  87. Webber, 2003, The importance of efflux pumps in bacterial antibiotic resistance, J. Antimicrob. Chemother., 51, 9, 10.1093/jac/dkg050 · DOI · Paper page
  88. Poole, 2004, Efflux-mediated multiresistance in Gram-negative bacteria, Clin. Microbiol. Infect., 10, 12, 10.1111/j.1469-0691.2004.00763.x · DOI · Paper page
  89. Blair, 2016, How to measure export via bacterial multidrug resistance efflux pumps, mBio, 7, e00840-16, 10.1128/mBio.00840-16 · doi:10.1128/mbio.00840-16
  90. Martins, 2013, A simple method for assessment of MDR bacteria for over-expressed efflux pumps, Open Microbiol. J., 7, 72, 10.2174/1874285801307010072 · DOI
  91. Whittle, 2019, Flow cytometric analysis of efflux by dye accumulation, Front. Microbiol., 10, 2319, 10.3389/fmicb.2019.02319 · DOI
  92. Chitsaz, 2017, The role played by drug efflux pumps in bacterial multidrug resistance, Essays Biochem., 61, 127, 10.1042/EBC20160064 · DOI
  93. Kumar, 2005, Bacterial resistance to antibiotics: Active efflux and reduced uptake, Adv. Drug Deliv. Rev., 57, 1486, 10.1016/j.addr.2005.04.004 · DOI · Paper page
  94. Alnaseri, 2015, Inducible expression of a resistance-nodulation-division-type efflux pump in Staphylococcus aureus provides resistance to linoleic and arachidonic acids, J. Bacteriol., 197, 1893, 10.1128/JB.02607-14 · DOI
  95. Lekshmi, 2018, Modulation of antimicrobial efflux pumps of the major facilitator superfamily in Staphylococcus aureus, AIMS Microbiol., 4, 1, 10.3934/microbiol.2018.1.1 · DOI
  96. Littlejohn, 1991, Structure and evolution of a family of genes encoding antiseptic and disinfectant resistance in Staphylococcus aureus, Gene, 101, 59, 10.1016/0378-1119(91)90224-Y · DOI
  97. Sasatsu, 1989, Nucleotide sequence of a gene that encodes resistance to ethidium bromide from a transferable plasmid in Staphylococcus aureus, Nucleic Acids Res., 17, 10103, 10.1093/nar/17.23.10103 · DOI
  98. Paulsen, 1995, Molecular characterization of the staphylococcal multidrug resistance export protein QacC, J. Bacteriol., 177, 2827, 10.1128/jb.177.10.2827-2833.1995 · DOI
  99. Poget, 2010, 1H, 13C, 15N backbone NMR assignments of the Staphylococcus aureus small multidrug-resistance pump (Smr) in a functionally active conformation, Biomol. NMR Assign., 4, 139, 10.1007/s12104-010-9228-7 · doi:10.1007/s12104-010-9228-7
  100. Putman, 2000, Molecular properties of bacterial multidrug transporters, Microbiol. Mol. Biol. Rev., 64, 672, 10.1128/MMBR.64.4.672-693.2000 · DOI · Paper page
  101. Li, X.Z., Elkins, C.A., and Zgurskaya, H.I. (2016). Small multidrug resistance efflux pumps. Efflux-Mediated Antimicrobial Resistance in Bacteria, Springer. · doi:10.1007/978-3-319-39658-3
  102. Grinius, 1994, Bacterial multidrug resistance is due to a single membrane protein which functions as a drug pump, J. Biol. Chem., 269, 29998, 10.1016/S0021-9258(18)43980-4 · DOI
  103. Bay, 2008, Small multidrug resistance proteins: A multidrug transporter family that continues to grow, Biochim. Biophys. Acta, 1778, 1814, 10.1016/j.bbamem.2007.08.015 · DOI · Paper page
  104. LaBreck, 2020, Systematic analysis of efflux pump-mediated antiseptic resistance in Staphylococcus aureus suggests a need for greater antiseptic stewardship, mSphere, 5, e00959-19, 10.1128/mSphere.00959-19 · DOI
  105. Leelaporn, 1995, Multidrug resistance plasmid pSK108 from coagulase-negative staphylococci; Relationships to Staphylococcus aureus qacC plasmids, Plasmid, 34, 62, 10.1006/plas.1995.1034 · doi:10.1006/plas.1995.1034
  106. Wassenaar, 2016, The qacC gene has recently spread between rolling circle plasmids of Staphylococcus, indicative of a novel gene transfer mechanism, Front. Microbiol., 7, 1528, 10.3389/fmicb.2016.01528 · DOI
  107. Wassenaar, 2015, Review and phylogenetic analysis of qac genes that reduce susceptibility to quaternary ammonium compounds in Staphylococcus species, Eur. J. Microbiol. Immunol., 5, 44, 10.1556/EuJMI-D-14-00038 · DOI · Paper page
  108. Littlejohn, 1992, Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus, FEMS Microbiol. Lett., 74, 259, 10.1111/j.1574-6968.1992.tb05376.x · DOI
  109. Horner, 2012, Reduced susceptibility to chlorhexidine in Staphylococci: Is it increasing and does it matter?, J. Antimicrob. Chemother., 67, 2547, 10.1093/jac/dks284 · DOI · Paper page
  110. Baines, 2019, Remodeling of pSK1 family plasmids and enhanced chlorhexidine tolerance in a dominant hospital lineage of methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 63, e02356-18, 10.1128/AAC.02356-18 · DOI
  111. Leelaporn, 1994, Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci, J. Med. Microbiol., 40, 214, 10.1099/00222615-40-3-214 · DOI · Paper page
  112. Smith, 2008, The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates, J. Antimicrob. Chemother., 61, 78, 10.1093/jac/dkm395 · DOI · Paper page
  113. Villet, 2014, Regulation of expression of abcA and its response to environmental conditions, J. Bacteriol., 196, 1532, 10.1128/JB.01406-13 · DOI
  114. Leclercq, 2011, Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus saprophyticus clinical isolates, Int. J. Antimicrob. Agents, 37, 118, 10.1016/j.ijantimicag.2010.10.008 · DOI
  115. Wang, 2019, Baicalin inhibits biofilm formation and the quorum-sensing system by regulating the MsrA drug efflux pump in Staphylococcus saprophyticus, Front. Microbiol., 10, 2800, 10.3389/fmicb.2019.02800 · DOI
  116. Dawson, 2007, Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP, FEBS Lett., 581, 935, 10.1016/j.febslet.2007.01.073 · DOI · Paper page
  117. Velamakanni, 2008, Multidrug transport by the ABC transporter Sav1866 from Staphylococcus aureus, Biochemistry, 47, 9300, 10.1021/bi8006737 · doi:10.1021/bi8006737
  118. Allignet, 1992, Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginiamycin A-like antibiotics, Gene, 117, 45, 10.1016/0378-1119(92)90488-B · DOI
  119. Vimberg, 2020, Ribosome-mediated attenuation of vga (A) expression is shaped by the antibiotic resistance specificity of Vga (A) protein variants, Antimicrob. Agents Chemother., 64, e00666-20, 10.1128/AAC.00666-20 · DOI
  120. Allignet, 1997, Characterization of a new staphylococcal gene, vgaB, encoding a putative ABC transporter conferring resistance to streptogramin A and related compounds, Gene, 202, 133, 10.1016/S0378-1119(97)00464-2 · DOI
  121. Chesneau, 2005, Molecular analysis of resistance to streptogramin A compounds conferred by the Vga proteins of staphylococci, Antimicrob. Agents Chemother., 49, 973, 10.1128/AAC.49.3.973-980.2005 · DOI
  122. Kaatz, 2005, Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein, Antimicrob. Agents Chemother., 49, 1857, 10.1128/AAC.49.5.1857-1864.2005 · DOI · Paper page
  123. McAleese, 2005, A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline, Antimicrob. Agents Chemother., 49, 1865, 10.1128/AAC.49.5.1865-1871.2005 · DOI · Paper page
  124. Tintino, 2021, Chemical synthesis, molecular docking and MepA efflux pump inhibitory effect by 1, 8-naphthyridines sulfonamides, Eur. J. Pharm. Sci., 160, 105753, 10.1016/j.ejps.2021.105753 · DOI
  125. Kehrenberg, 2005, Florfenicol-chloramphenicol exporter gene fexA is part of the novel transposon Tn558, Antimicrob. Agents Chemother., 49, 813, 10.1128/AAC.49.2.813-815.2005 · DOI
  126. Floyd, 2010, LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus, Antimicrob. Agents Chemother., 54, 5406, 10.1128/AAC.00580-10 · DOI · Paper page
  127. Nava, 2020, Evidence of calcium signaling and modulation of the LmrS multidrug resistant efflux pump activity by Ca2+ ions in S. aureus, Front. Microbiol., 11, 573388, 10.3389/fmicb.2020.573388 · DOI
  128. Huang, 2004, Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus, Antimicrob. Agents Chemother., 48, 909, 10.1128/AAC.48.3.909-917.2004 · DOI
  129. Yamada, 2006, Functional gene cloning and characterization of MdeA, a multidrug efflux pump from Staphylococcus aureus, Biol. Pharm. Bull., 29, 801, 10.1248/bpb.29.801 · doi:10.1248/bpb.29.801
  130. Yu, 2002, NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes, J. Bacteriol., 184, 1370, 10.1128/JB.184.5.1370-1377.2002 · DOI
  131. Costa, 2019, Genetic diversity of norA, coding for a main efflux pump of Staphylococcus aureus, Front. Genet., 9, 710, 10.3389/fgene.2018.00710 · DOI
  132. Hooper, 2010, Phosphorylation of MgrA and its effect on expression of the NorA and NorB efflux pumps of Staphylococcus aureus, J. Bacteriol., 192, 2525, 10.1128/JB.00018-10 · DOI
  133. Rajabi, 2020, Evaluation of multidrug efflux pump expression in clinical isolates of Staphylococcus aureus, Gene Rep., 18, 100537, 10.1016/j.genrep.2019.100537 · DOI
  134. Strahilevitz, 2006, NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus, Antimicrob. Agents Chemother., 50, 1104, 10.1128/AAC.50.3.1104-1107.2006 · DOI
  135. Kumar, 2020, Isolation and structural characterization of a Zn2+-bound single-domain antibody against NorC, a putative multidrug efflux transporter in bacteria, J. Biol. Chem., 295, 55, 10.1074/jbc.RA119.010902 · DOI
  136. Paulsen, 1996, Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: Membrane topology and identification of residues involved in substrate specificity, Proc. Natl. Acad. Sci. USA, 93, 3630, 10.1073/pnas.93.8.3630 · DOI · Paper page
  137. Mitchell, 1998, QacA multidrug efflux pump from Staphylococcus aureus: Comparative analysis of resistance to diamidines, biguanidines, and guanylhydrazones, Antimicrob. Agents Chemother., 42, 475, 10.1128/AAC.42.2.475 · DOI
  138. Majumder, 2019, Dissection of protonation sites for antibacterial recognition and transport in QacA, a multi-drug efflux transporter, J. Mol. Biol., 431, 2163, 10.1016/j.jmb.2019.03.015 · DOI
  139. Hassanzadeh, 2020, Epidemiology of efflux pumps genes mediating resistance among Staphylococcus aureus; A systematic review, Microb. Pathog., 139, 103850, 10.1016/j.micpath.2019.103850 · DOI
  140. Yamada, 2006, Gene cloning and characterization of SdrM, a chromosomally-encoded multidrug efflux pump, from Staphylococcus aureus, Biol. Pharm. Bull., 29, 554, 10.1248/bpb.29.554 · DOI
  141. Ginn, 2000, The TetA (K) tetracycline/H+ antiporter from Staphylococcus aureus: Mutagenesis and functional analysis of motif C, J. Bacteriol., 182, 1492, 10.1128/JB.182.6.1492-1498.2000 · DOI
  142. Wang, 2018, Tet38 efflux pump contributes to fosfomycin resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 62, e00927-18, 10.1128/AAC.00927-18 · doi:10.1128/aac.00927-18
  143. Nguyen, 2019, Inactivation of farR causes high rhodomyrtone resistance and increased pathogenicity in Staphylococcus aureus, Front. Microbiol., 10, 1157, 10.3389/fmicb.2019.01157 · DOI
  144. Scherf, 2020, Effect of terpinolene against the resistant Staphylococcus aureus strain, carrier of the efflux pump QacC and β-lactamase gene, and its toxicity in the Drosophila melanogaster model, Microb. Pathog., 149, 104528, 10.1016/j.micpath.2020.104528 · doi:10.1016/j.micpath.2020.104528
  145. Bjorland, 2003, Novel plasmid-borne gene qacJ mediates resistance to quaternary ammonium compounds in equine Staphylococcus aureus, Staphylococcus simulans, and Staphylococcus intermedius, Antimicrob. Agents Chemother., 47, 3046, 10.1128/AAC.47.10.3046-3052.2003 · DOI
  146. Heir, 1999, The qacG gene on plasmid pST94 confers resistance to quaternary ammonium compounds in staphylococci isolated from the food industry, J. Appl. Microbiol., 86, 378, 10.1046/j.1365-2672.1999.00672.x · DOI
  147. Heir, 1998, The Staphylococcus qacH gene product: A new member of the SMR family encoding multidrug resistance, FEMS Microbiol. Lett., 163, 49, 10.1111/j.1574-6968.1998.tb13025.x · DOI
  148. Narui, 2002, Cloning and characterization of a novel chromosomal drug efflux gene in Staphylococcus aureus, Biol. Pharm. Bull., 25, 1533, 10.1248/bpb.25.1533 · DOI
  149. Schindler, 2016, Multidrug efflux pumps of Gram-positive bacteria, Drug Resist. Updates, 27, 1, 10.1016/j.drup.2016.04.003 · DOI · Paper page
  150. Omote, 2006, The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations, Trends Pharmacol. Sci., 27, 587, 10.1016/j.tips.2006.09.001 · DOI · Paper page
  151. Kaatz, 2006, MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein, Antimicrob. Agents Chemother., 50, 1276, 10.1128/AAC.50.4.1276-1281.2006 · DOI
  152. Schindler, 2013, Mutagenesis and modeling to predict structural and functional characteristics of the Staphylococcus aureus MepA multidrug efflux pump, J. Bacteriol., 195, 523, 10.1128/JB.01679-12 · doi:10.1128/jb.01679-12
  153. Huet, 2008, Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes, Microbiology, 154, 3144, 10.1099/mic.0.2008/021188-0 · DOI
  154. Fang, 2020, Mutations in the MepRAB efflux system contribute to the in vitro development of tigecycline resistance in Staphylococcus aureus, J. Glob. Antimicrob. Resist., 22, 631, 10.1016/j.jgar.2020.06.005 · doi:10.1016/j.jgar.2020.06.005
  155. Birukou, 2014, Structural mechanism of transcription regulation of the Staphylococcus aureus multidrug efflux operon mepRA by the MarR family repressor MepR, Nucleic Acids Res., 42, 2774, 10.1093/nar/gkt1215 · doi:10.1093/nar/gkt1215
  156. Rees, 2009, ABC transporters: The power to change, Nat. Rev. Mol. Cell Biol., 10, 218, 10.1038/nrm2646 · DOI · Paper page
  157. 2001, The AbcA transporter of Staphylococcus aureus affects cell autolysis, Antimicrob. Agents Chemother., 45, 407, 10.1128/AAC.45.2.407-412.2001 · DOI
  158. Dawson, 2006, Structure of a bacterial multidrug ABC transporter, Nature, 443, 180, 10.1038/nature05155 · DOI · Paper page
  159. Stockner, 2009, Data-driven homology modelling of P-glycoprotein in the ATP-bound state indicates flexibility of the transmembrane domains, FEBS J., 276, 964, 10.1111/j.1742-4658.2008.06832.x · DOI
  160. Reynolds, 2003, Msr(A) and related macrolide/streptogramin resistance determinants: Incomplete transporters?, Int. J. Antimicrob. Agents, 22, 228, 10.1016/S0924-8579(03)00218-8 · DOI
  161. Quistgaard, 2016, Understanding transport by the major facilitator superfamily (MFS): Structures pave the way, Nat. Rev. Mol. Cell Biol., 17, 123, 10.1038/nrm.2015.25 · DOI · Paper page
  162. Saier, 2014, The transporter classification database, Nucleic Acids Res., 42, D251, 10.1093/nar/gkt1097 · DOI · Paper page
  163. Reddy, 2012, The major facilitator superfamily (MFS) revisited, FEBS J., 279, 2022, 10.1111/j.1742-4658.2012.08588.x · DOI · Paper page
  164. Jin, 2001, Twelve-transmembrane-segment (TMS) version (DeltaTMS VII-VIII) of the 14-TMS Tet(L) antibiotic resistance protein retains monovalent cation transport modes but lacks tetracycline efflux capacity, J. Bacteriol., 183, 2667, 10.1128/JB.183.8.2667-2671.2001 · DOI
  165. Tanabe, 2009, The multidrug resistance efflux complex, EmrAB from Escherichia coli forms a dimer in vitro, Biochem. Biophys. Res. Commun., 380, 338, 10.1016/j.bbrc.2009.01.081 · DOI
  166. Li, 2004, Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis, Antimicrob. Agents Chemother., 48, 2415, 10.1128/AAC.48.7.2415-2423.2004 · DOI · Paper page
  167. Saier, 2003, Tracing pathways of transport protein evolution, Mol. Microbiol., 48, 1145, 10.1046/j.1365-2958.2003.03499.x · DOI
  168. Hassan, 2007, Active export proteins mediating drug resistance in staphylococci, J. Mol. Microbiol. Biotechnol., 12, 180
  169. Ganesan, 2016, Identification of benzochromene derivatives as a highly specific NorA efflux pump inhibitor to mitigate the drug resistant strains of S. aureus, RSC Adv., 6, 30258, 10.1039/C6RA01981A · DOI
  170. Yoshida, 1990, Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones, J. Bacteriol., 172, 6942, 10.1128/jb.172.12.6942-6949.1990 · DOI · Paper page
  171. Palazzotti, D., Bissaro, M., Bolcato, G., Astolfi, A., Felicetti, T., Sabatini, S., Sturlese, M., Cecchetti, V., Barreca, M.L., and Moro, S. (2019). Deciphering the molecular recognition mechanism of multidrug resistance Staphylococcus aureus NorA efflux pump using a supervised molecular dynamics approach. Int. J. Mol. Sci., 20. · doi:10.3390/ijms20164041
  172. Neyfakh, 1993, Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter, Antimicrob. Agents Chemother., 37, 128, 10.1128/AAC.37.1.128 · DOI · Paper page
  173. Buonerba, 2017, Improved potency of indole-based NorA efflux pump inhibitors: From serendipity toward rational design and development, J. Med. Chem., 60, 517, 10.1021/acs.jmedchem.6b01281 · DOI
  174. Zimmermann, 2017, Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus, J. Microbiol. Methods, 142, 39, 10.1016/j.mimet.2017.09.001 · doi:10.1016/j.mimet.2017.09.001
  175. Handzlik, 2013, Recent advances in multi-drug resistance (MDR) efflux pump inhibitors of Gram-positive bacteria S. aureus, Antibiotics, 2, 28, 10.3390/antibiotics2010028 · DOI · Paper page
  176. Espinoza, 2019, Essential oil, extracts, and sesquiterpenes obtained from the heartwood of pilgerodendron uviferum act as potential inhibitors of the Staphylococcus aureus NorA multidrug efflux pump, Front. Microbiol., 10, 337, 10.3389/fmicb.2019.00337 · DOI
  177. AlMatar, 2021, Efflux pump inhibitors: New updates, Pharmacol. Rep., 73, 1, 10.1007/s43440-020-00160-9 · DOI
  178. Bhaskar, 2016, Homology modeling, molecular dynamics, and virtual screening of NorA efflux pump inhibitors of Staphylococcus aureus, Drug Des. Devel. Ther., 10, 3237, 10.2147/DDDT.S113556 · DOI
  179. Thakur, 2021, A comprehensive review on pharmacology of efflux pumps and their inhibitors in antibiotic resistance, Eur. J. Pharmacol., 903, 174151, 10.1016/j.ejphar.2021.174151 · DOI
  180. Costa, 2016, Inhibition of the NorA efflux pump of Staphylococcus aureus by synthetic riparins, J. Appl. Microbiol., 121, 1312, 10.1111/jam.13258 · DOI
  181. Felicetti, 2017, Searching for novel inhibitors of the S. aureus NorA efflux pump: Synthesis and biological evaluation of the 3-Phenyl-1,4-benzothiazine Analogues, ChemMedChem, 12, 1293, 10.1002/cmdc.201700286 · DOI
  182. Singh, 2017, Boeravinone B, a novel dual inhibitor of NorA bacterial efflux pump of Staphylococcus aureus and human P-glycoprotein, reduces the biofilm formation and intracellular invasion of bacteria, Front. Microbiol., 8, 1868, 10.3389/fmicb.2017.01868 · DOI
  183. Ding, 2008, NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses, J. Bacteriol., 190, 7123, 10.1128/JB.00655-08 · DOI · Paper page
  184. Dunman, 2005, MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus, J. Bacteriol., 187, 2395, 10.1128/JB.187.7.2395-2405.2005 · DOI · Paper page
  185. Hooper, 2015, Mechanisms of drug resistance: Quinolone resistance, Ann. N. Y. Acad. Sci., 1354, 12, 10.1111/nyas.12830 · DOI · Paper page
  186. Hsing, 2012, Reduced aeration affects the expression of the NorB efflux pump of Staphylococcus aureus by posttranslational modification of MgrA, J. Bacteriol., 194, 1823, 10.1128/JB.06503-11 · DOI
  187. Briaud, 2019, Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells, Sci. Rep., 9, 1, 10.1038/s41598-019-52975-z · DOI
  188. Villet, 2014, Native efflux pumps contribute resistance to antimicrobials of skin and the ability of Staphylococcus aureus to colonize skin, J. Infect. Dis., 209, 1485, 10.1093/infdis/jit660 · DOI
  189. Pasqua, M., Grossi, M., Zennaro, A., Fanelli, G., Micheli, G., Barras, F., Colonna, B., and Prosseda, G. (2019). The varied role of efflux pumps of the MFS family in the interplay of bacteria with animal and plant cells. Microorganisms, 7. · DOI
  190. Kumar, 2021, Structural basis of inhibition of a transporter from Staphylococcus aureus, NorC, through a single-domain camelid antibody, Commun. Biol., 4, 1, 10.1038/s42003-021-02357-x · DOI
  191. Guay, 1993, Expression of the tetK gene from Staphylococcus aureus in Escherichia coli: Comparison of substrate specificities of TetA (B), TetA (C), and TetK efflux proteins, Antimicrob. Agents Chemother., 37, 191, 10.1128/AAC.37.2.191 · DOI
  192. Guay, 1993, The tet (K) gene of plasmid pT181 of Staphylococcus aureus encodes an efflux protein that contains 14 transmembrane helices, Plasmid, 30, 163, 10.1006/plas.1993.1045 · DOI · Paper page
  193. Ginn, 1997, Membrane topology of the metal-tetracycline/H+ antiporter TetA (K) from Staphylococcus aureus, J. Bacteriol., 179, 3786, 10.1128/jb.179.11.3786-3789.1997 · doi:10.1128/jb.179.11.3786-3789.1997
  194. Jin, 2002, Tet (L) and tet (K) tetracycline-divalent metal/H+ antiporters: Characterization of multiple catalytic modes and a mutagenesis approach to differences in their efflux substrate and coupling ion preferences, J. Bacteriol., 184, 4722, 10.1128/JB.184.17.4722-4732.2002 · doi:10.1128/jb.184.17.4722-4732.2002
  195. Wang, 2000, Two types of Bacillus subtilis tetA (L) deletion strains reveal the physiological importance of TetA (L) in K+ acquisition as well as in Na+, alkali, and tetracycline resistance, J. Bacteriol., 182, 2088, 10.1128/JB.182.8.2088-2095.2000 · DOI
  196. Krulwich, 2001, Functions of tetracycline efflux proteins that do not involve tetracycline, J. Mol. Microbiol. Biotechnol., 3, 237
  197. Wang, 2019, Tet38 of Staphylococcus aureus binds to host cell receptor complex CD36-Toll-like receptor 2 and protects from teichoic acid synthesis inhibitors tunicamycin and Congo red, Infect. Immun., 87, e00194-19, 10.1128/IAI.00194-19 · doi:10.1128/iai.00194-19
  198. Fu, 2016, Prevalence of fosfomycin resistance and mutations in murA, glpT, and uhpT in methicillin-resistant Staphylococcus aureus strains isolated from blood and cerebrospinal fluid samples, Front. Microbiol., 6, 1544, 10.3389/fmicb.2015.01544 · doi:10.3389/fmicb.2015.01544
  199. Bolduc, 2015, Role of the Tet38 efflux pump in Staphylococcus aureus internalization and survival in epithelial cells, Infect. Immun., 83, 4362, 10.1128/IAI.00723-15 · DOI
  200. Wang, 2021, Staphylococcus aureus Tet38 efflux pump structural modeling and roles of essential residues in drugs efflux and host cell internalization, Infect. Immun., 89, e00811-20, 10.1128/IAI.00811-20 · doi:10.1128/iai.00811-20

200 of 296 shown

Cited by

See all 115

Metadata

Authors
Dashtbani-Roozbehani, A., & Brown, M. H.
Venue
Antibiotics
Publisher
MDPI AG
Published
2021-12-07
Volume
10
Issue
12
Pages
1502
ISSN
2079-6382
Cited by
115
References
9
Language
en
Funders
Flinders University (-)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition. https://app.cochat.ai/papers/10.3390/antibiotics10121502
The paper
Dashtbani-Roozbehani, A., & Brown, M. H. (2021). Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition. Antibiotics. https://doi.org/10.3390/antibiotics10121502

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.